Email updates

Keep up to date with the latest news and content from JNI and BioMed Central.

Open Access Highly Accessed Research

A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization

Sven Jarius1*, Klaus P Wandinger23, Sigrun Horn4, Heike Heuer4 and Brigitte Wildemann1

Author Affiliations

1 Division of Molecular Neuroimmunology, Department of Neurology, University of Heidelberg, Heidelberg, Germany

2 Institute for Neuroimmunology and Clinical MS Research, Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Eppendorf, Hamburg, Germany

3 Institute for Experimental Immunology, affiliated to Euroimmun, Luebeck, Germany

4 Leibniz Institute for Age Research/Fritz Lipmann Institute, Jena, Germany

For all author emails, please log on.

Journal of Neuroinflammation 2010, 7:21  doi:10.1186/1742-2094-7-21

Published: 12 March 2010

Abstract

We report on a newly discovered serum and cerebrospinal fluid (CSF) reactivity to Purkinje cells (PCs) associated with subacute inflammatory cerebellar ataxia. The patient, a previously healthy 33-year-old lady, presented with severe limb and gait ataxia, dysarthria, and diplopia two weeks after she had recovered from a common cold. Immunohistochemical studies on mouse, rat, and monkey brain sections revealed binding of a high-titer (up to 1:10,000) IgG antibody to the cerebellar molecular layer, Purkinje cell (PC) layer, and white matter. The antibody is highly specific for PCs and binds to the cytoplasm as well as to the inner side of the membrane of PC somata, dendrites and axons. It is produced by B cell clones within the CNS, belongs to the IgG1 subclass, and activates complement in vitro. Western blotting of primate cerebellum extract revealed binding of CSF and serum IgG to an 80-97 kDa protein. Extensive control studies were performed to rule out a broad panel of previously described paraneoplastic and non-paraneoplastic antibodies known to be associated with cerebellar ataxia. Screening of >9000 human full length proteins by means of a protein array and additional confirmatory experiments revealed Rho GTPase activating protein 26 (ARHGAP26, GRAF, oligophrenin-1-like protein) as the target antigen. Preadsorption of the patient's serum with human ARHGAP26 but not preadsorption with other proteins resulted in complete loss of PC staining. Our findings suggest a role of autoimmunity against ARHGAP26 in the pathogenesis of subacute inflammatory cerebellar ataxia, and extend the panel of diagnostic markers for this devastating disease.